1. Home
  2. TU vs BNTX Comparison

TU vs BNTX Comparison

Compare TU & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Telus Corporation

TU

Telus Corporation

HOLD

Current Price

$13.12

Market Cap

22.9B

ML Signal

HOLD

Logo BioNTech SE

BNTX

BioNTech SE

HOLD

Current Price

$96.50

Market Cap

24.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TU
BNTX
Founded
1993
2008
Country
Canada
Germany
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.9B
24.8B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
TU
BNTX
Price
$13.12
$96.50
Analyst Decision
Hold
Buy
Analyst Count
3
11
Target Price
$18.17
$137.40
AVG Volume (30 Days)
6.0M
1.2M
Earning Date
02-12-2026
11-03-2025
Dividend Yield
9.05%
N/A
EPS Growth
24.25
N/A
EPS
0.56
N/A
Revenue
$14,679,551,147.00
$3,698,814,972.00
Revenue This Year
$2.94
$2.03
Revenue Next Year
$2.40
N/A
P/E Ratio
$24.01
N/A
Revenue Growth
2.42
3.70
52 Week Low
$12.54
$81.20
52 Week High
$16.74
$129.27

Technical Indicators

Market Signals
Indicator
TU
BNTX
Relative Strength Index (RSI) 49.23 51.70
Support Level $12.78 $94.00
Resistance Level $12.96 $95.71
Average True Range (ATR) 0.16 1.72
MACD 0.11 0.62
Stochastic Oscillator 81.65 81.33

Price Performance

Historical Comparison
TU
BNTX

About TU Telus Corporation

Telus is one of the Big Three wireless service providers in Canada, with over 10 million mobile phone subscribers nationwide constituting almost 30% of the total market. It is the incumbent local exchange carrier in the western Canadian provinces of British Columbia and Alberta, where it provides internet, television, and landline phone services. It also has a small wireline presence in eastern Quebec. Mostly because of recent acquisitions, more than 20% of Telus' sales now come from nontelecom businesses, most notably in the international business services, health, security, and agriculture industries. The firm has a 55% economic stake in Telus International.

About BNTX BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.

Share on Social Networks: